Most scientific discoveries never leave the lab. The ones that do? They need someone who understands both the science and the business.Dr. Oliver Uecke is that person.As COO of Lipotype GmbH — a pioneer in large-scale lipidomics analysis — Oliver has spent his career at the exact intersection where research becomes reality. With a doctorate focused on commercializing biotechnology research, he's helped translate academic discoveries into real companies at TU Dresden's "dresden exists" initiative and the Max Planck Institute of Molecular Cell Biology and Genetics. Today he also serves as Chairman of the Executive Board of biosaxony, helping shape one of Europe's emerging biotech clusters.In this episode, Oliver shares his full journey — from growing up with an interest in business, to studying business administration, to finding his way into one of the most scientifically demanding industries in the world. He opens up about what technology transfer actually looks like from the inside, why so many commercialization efforts fail, and what it took to scale Lipotype into the US market.We also break down lipidomics from scratch — what it is, why it matters for precision medicine, and why it's becoming impossible to ignore.Whether you're a scientist thinking about life beyond the bench, an entrepreneur navigating deep-tech, or just curious about how biotech companies actually get built — this episode is for you.🧬 What we cover:00:00 IntroductionCareer journey: from business studies to biotech COOWhat he learned supporting startups at TU Dresden's "dresden exists"The real challenges of technology transfer at the Max Planck InstituteKey insights from his PhD on commercializing biotech researchCommon mistakes universities make when trying to spin out companiesWhat lipidomics is and why it's becoming critical in precision medicineHow Lipotype expanded into the US — and what it actually cost themBalancing scientific innovation with commercial realityWhy regional biotech clusters like biosaxony matter more than people thinkHow Germany's biotech ecosystem has evolvedSkills scientists need to transition into biotech business and leadershipWhat he'd do differently — and his advice for aspiring biotech foundersThe lipidomics and biotech developments he's most excited about in the next decade🔗 Connect & Learn More:🎙️ Biology Career Insights Podcast — exploring the careers shaping the future of biotech🔬 Lipotype GmbH: https://www.lipotype.com🌐 biosaxony: https://www.biosaxony.com